Articles | EuroIntervention

Intro editorial

Feb 16, 2026

A State-of-the-Art on adjunctive pharmacological strategies for residual risk; a consensus statement on day-case PCI; aspirin discontinuation timing in ACS; 7-year outcomes in COMPARE-ABSORB; the PINNACLE-I trial; a novel spacer for tricuspid regurgitation treatment; news from PCR; and more

Capodanno D

free

Viewpoint

Feb 16, 2026

PCR: a new era dawns

Prendergast B

free

Editorial

10.4244/EIJ-D-25-01330 • Feb 16, 2026

Aspirin discontinuation after ACS: timing the transition to ticagrelor monotherapy

Gragnano F, Calabrò P

free

Editorial

10.4244/EIJ-D-25-01331 • Feb 16, 2026

Will the dream of "leave nothing behind" remain a utopia if we forget to optimise the systemic medical therapy?

Wykrzykowska J, Kraak R

free

State-of-the-Art

10.4244/EIJ-D-25-00598 • Feb 16, 2026

Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation

Oshima A, Serruys P, Garg S, McEvoy J, Wood D, Doenst T, Taggart D, Puskas J, Shajahan A, Sharif F, Miyashita K, Tobe A, Tsai T, Revaiah P, Dunne F, Mehran R, Budoff M, Kastelein J, Stroes E, Khamis R, Koenig W, Onuma Y

free

Consensus Document

10.4244/EIJ-D-25-00326 • Feb 16, 2026

Day-case percutaneous coronary procedures. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology (ESC) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC

Toth G, Amabile N, Barbato E, Borregaard B, Buszman P, Cuisset T, Gilard M, James S, Al-Lamee R, Mashayekhi K, Regazzoli D, Sarno G, Siller-Matula J, Brugaletta S, Stefanini G

free

Original Research

10.4244/EIJ-D-25-00832 • Feb 16, 2026

Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials

Lee J, Lee J, Kim SY, Jeon HS, Lee J, Ahn SG, Lee Y, Lee S, Ahn C, Kim J, Kim B, Ko Y, Choi D, Hong M, Jang Y, Hong S, Youn YJ

Original Research

10.4244/EIJ-D-25-00778 • Feb 16, 2026

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

Smits P, Wlodarczak A, Chevalier B, West N, Gori T, Abdel-Wahab M, Barbato E, Esposito G, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Tijssen J, Rademaker-Havinga T, Serruys P, Morice M, Onuma Y, Geuns R, behalf of the COMPARE-ABSORB trial investigators o